havencrest.com

What It Is

Havencrest Capital Management is a U.S.-based private equity (PE) investment firm founded in 2018 by veteran healthcare investor Dr. Christopher W. Kersey. Unlike a payment gateway or fintech service provider, Havencrest focuses on the lower middle-market healthcare sector, aiming to transform the delivery of healthcare services in the United States through capital investment and operational enablement.

Core Dimension Analysis

• Service Type: Private equity investment; not payment processing or SaaS.
• Covered Countries/Regions: U.S. market only, with portfolio companies located in states such as Texas, North Carolina, and Indiana.
• Compliance and Licenses: As a PE fund, it is subject to relevant U.S. securities and private fund regulations, but the text does not disclose specific financial license information.
• Risk Management Capabilities: Backed by a team of 10 investment professionals and up to 31 operating partners, it drives enterprise value creation and manages investment risk through deep involvement in post-investment management, including strategy and operational guidance.
• Payment/API Dimensions: Completely not applicable.

Pricing

As a PE fund, its revenue model typically consists of a management fee (commonly 2%) and carried interest/performance-based profit sharing (commonly 20%), but the text does not disclose specific rates. Its second fund, Havencrest Healthcare Partners II, LP, is known to have been raised in 2022 with a size of $356 million.

Pros and Cons

Pros: Deep specialization in the healthcare vertical with a very high level of expertise; founder-friendly, emphasizing partnership and mutual success; large operating partner team with strong post-investment value-creation capabilities; more than $600 million in capital, providing ample financial resources.
Cons: Extremely narrow business scope, limited to the U.S. healthcare industry; offers no practical reference value for companies looking for payment solutions or fintech infrastructure.

Best For

U.S.-based, founder-led healthcare companies in high-growth stages—such as clinical trial networks, healthcare staffing, home care, behavioral health, and hospice care businesses—that have equity financing or partial exit needs.

Access from China

Unknown. As a U.S.-based PE firm website, it is typically not subject to special blocking, but the text does not provide any network connectivity information.